+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomaterials for Artificial Organs

  • ID: 3744663
  • Book
  • 320 Pages
  • Elsevier Science and Technology
1 of 3
The worldwide demand for organ transplants far exceeds available donor organs. Consequently some patients die whilst waiting for a transplant. Synthetic alternatives are therefore imperative to improve the quality of, and in some cases, save people's lives. Advances in biomaterials have generated a range of materials and devices for use either outside the body or through implantation to replace or assist functions which may have been lost through disease or injury. Biomaterials for artificial organs reviews the latest developments in biomaterials and investigates how they can be used to improve the quality and efficiency of artificial organs.

Part one discusses commodity biomaterials including membranes for oxygenators and plasmafilters, titanium and cobalt chromium alloys for hips and knees, polymeric joint-bearing surfaces for total joint replacements, biomaterials for pacemakers, defibrillators and neurostimulators and mechanical and bioprosthetic heart valves. Part two goes on to investigate advanced and next generation biomaterials including small intestinal submucosa and other decullarized matrix biomaterials for tissue repair, new ceramics and composites for joint replacement surgery, biomaterials for improving the blood and tissue compatibility of total artificial hearts (TAH) and ventricular assist devices (VAD), nanostructured biomaterials for artificial tissues and organs and matrices for tissue engineering and regenerative medicine.

With its distinguished editors and international team of contributors Biomaterials for artificial organs is an invaluable resource to researchers, scientists and academics concerned with the advancement of artificial organs.

- Reviews the latest developments in biomaterials and investigates how they can be used to improve the quality and efficiency of artificial organs
- Discusses commodity biomaterials including membranes for oxygenators and cobalt chromium alloys for hips and knees and polymeric joint-bearing surfaces for total joint replacements
- Further biomaterials utilised in pacemakers, defibrillators, neurostimulators and mechanical and bioprosthetic heart valve are also explored
Note: Product cover images may vary from those shown
2 of 3
Part 1 Commodity biomaterials: Membranes for oxygenators and plasmafilters: Titanium and cobalt-chromium alloys for hips and knees
Polymeric joint bearing surfaces for total joint replacements
Biomaterials for pacemakers, defibrillators and neurostimulators
Mechanical and bioprosthetic valves. Part 2 Advanced and next generation biomaterials: Small intestinal submucosa and other decullarized matrix biomaterials for tissue repair
New ceramics and composites for joint replacement surgery
Biomaterials for improving the blood and tissue compatibility of Total Artificial Hearts (TAH) and Ventricular Assist Devices (VAD)
Nanostructured biomaterials for artificial tissues and organs
Matrices for tissue engineering and regenerative medicine.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Lysaght, Michael
Dr. Michael Lysaght was the Founder and Director Emeritus of Brown University, USA's Center for Biomedical Engineering, and a retired member of the Brown Faculty. He sadly passed away before he could see this finished book and remains a widely recognized and well-respected figure in the field of biomedical engineering for his contributions to organ replacement technology.
Webster, Thomas J
Dr Thomas J. Webster is an associate professor for the Division of Engineering and Department of Orthopaedics at Brown University, USA. He directs the Nanomedicine laboratory which designs, synthesizes, and evaluates nanomaterials for various implant applications and is noted for his work in this area.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/3744663
Adroll
adroll